Quick Med Company Insiders
| QMDT Stock | USD 0.0001 0.00 0.00% |
Quick Med employs about 5 people. The company is managed by 2 executives with a total tenure of roughly 25 years, averaging almost 12.0 years of service per executive, having 2.5 employees per reported executive. Breaking down Quick Med's management performance can provide insight into the firm performance.
| Gregory Schultz Chairman Chairman of the Board |
| Bernd Liesenfeld President Principal Executive Officer and President and Director |
Quick |
Quick Med Management Team Effectiveness
The company has return on total asset (ROA) of (0.3521) % which means that it has lost $0.3521 on every $100 spent on assets. This is way below average. Quick Med's management efficiency ratios could be used to measure how well Quick Med manages its routine affairs as well as how well it operates its assets and liabilities.Quick Med Workforce Comparison
Quick Med Technologies is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 706. Quick Med maintains roughly 5.0 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4. Quick Med Technologies Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Quick Med Technologies Price Series Summation is a cross summation of Quick Med price series and its benchmark/peer.
Quick Med Notable Stakeholders
A Quick Med stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Quick Med often face trade-offs trying to please all of them. Quick Med's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Quick Med's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gregory Schultz | Chairman of the Board | Profile | |
| Bernd Liesenfeld | Principal Executive Officer and President and Director | Profile |
About Quick Med Management Performance
The success or failure of an entity such as Quick Med Technologies often depends on how effective the management is. Quick Med management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quick management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quick management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. The company was founded in 1997 and is headquartered in Gainesville, Florida. Quick-Med Technolog operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.
Please note, the imprecision that can be found in Quick Med's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Quick Med Technologies. Check Quick Med's Beneish M Score to see the likelihood of Quick Med's management manipulating its earnings.
Quick Med Workforce Analysis
Traditionally, organizations such as Quick Med use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Quick Med within its industry.Quick Med Manpower Efficiency
Return on Quick Med Manpower
| Revenue Per Employee | 185.7K | |
| Revenue Per Executive | 464.2K | |
| Net Loss Per Employee | 142.6K | |
| Net Loss Per Executive | 356.5K |
Additional Tools for Quick Pink Sheet Analysis
When running Quick Med's price analysis, check to measure Quick Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quick Med is operating at the current time. Most of Quick Med's value examination focuses on studying past and present price action to predict the probability of Quick Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quick Med's price. Additionally, you may evaluate how the addition of Quick Med to your portfolios can decrease your overall portfolio volatility.